Sign In
Buy SNY
$42.37
-0.430 (-1.00%)
At Close: Jun 03, 2026
Press Release: Sanofi completes acquisition of DR-0201
01:00am, Tuesday, 27'th May 2025
Sanofi completes acquisition of DR-0201 Paris, May 27, 2025. Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private c
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of V
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence
05:30pm, Thursday, 22'nd May 2025
MORRISTOWN, N.J. , May 22, 2025 /PRNewswire/ -- Sanofi today announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboratio
Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout
11:15am, Thursday, 22'nd May 2025
SNY inks an agreement to acquire VIGL and its pipeline candidate VG-3927, which is being developed to treat Alzheimer's disease.
Sanofi to Buy Vigil Neuroscience for About $470 Million
07:59pm, Wednesday, 21'st May 2025
Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational treatment for Alzheimer's disease to the French pharmaceutical company's pipe
Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi
07:30pm, Wednesday, 21'st May 2025
- Vigil's shareholders to receive up to $10.00 per share in cash, comprised of $8.00 per share in cash at closing and a non-tradeable contingent value right of $2.00 per share in cash following the fi
Sanofi to acquire Vigil Neuroscience in $470 million deal
07:29pm, Wednesday, 21'st May 2025
Sanofi said on Thursday that it would acquire Vigil Neuroscience, a clinical-stage biotech company, for $8 per share in cash, valuing the deal at about $470 million.
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer's disease to the neurology pipeline
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year partnership with Sanofi (NASDAQ: SNY), an innov
French finance minister criticises Sanofi's $20 bln USA investment decision
12:55pm, Thursday, 15'th May 2025
France's finance minister criticised on Thursday a decision by French drugmaker Sanofi to invest at least $20 billion in the United States through to 2030, as France aims to get more companies investi
Sanofi to invest at least $20 billion in the US through 2030
12:42pm, Wednesday, 14'th May 2025
French drugmaker Sanofi said on Wednesday it plans to invest at least $20 billion in the United States through 2030, which includes an increase in research and development spending and the allocation
Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing
12:30pm, Wednesday, 14'th May 2025
MORRISTOWN, N.J. and CAMBRIDGE, Mass.
Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label
08:35pm, Friday, 09'th May 2025
Hawaii said on Friday it entered a $700 million settlement deal with pharmaceutical firm Bristol-Myers Squibb and units of French pharmaceutical company Sanofi in a case about warning labels related t
Pressure is still on the pharma sector, says Mizuho's Jared Holz
07:23pm, Thursday, 08'th May 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk headwinds to the pharma sector.
Sanofi: Investing in prevention builds Europe's health and competitiveness
07:08am, Tuesday, 06'th May 2025
WARSAW, Poland, May 06, 2025 (GLOBE NEWSWIRE) -- As the Polish Presidency of the EU Council enters its final stage health policy remains central to Europe's strategic agenda. At the European Economic
